受体相互作用蛋白激酶-3 (RIPK3):一种新的生物标志物用于早产婴儿中死性肠球炎
Lirong Shen1, Zuming Yang1, Chuchu Gao1
1Department of Neonatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu Province, China.
Pediatric surgery international
|May 2, 2024
概括
与受体相互作用的蛋白激酶-3 (RIPK3) 显示为在早产婴儿中诊断死亡性肠球炎 (NEC) 的生物标志物具有前途. 较高的RIPK3水平有助于评估疾病的严重程度,并指导康复后的养策略.
科学领域:
- 新生儿医学 新生儿医学
- 生物标志物发现发现
- 胃肠病学 胃肠病学
背景情况:
- 死性肠球炎 (NEC) 是早产婴儿的严重胃肠道紧急情况.
- 准确的诊断和NEC的严重程度评估对于患者的治疗结果至关重要.
- 需要新的生物标志物来改善NEC管理.
研究的目的:
- 评估受体相互作用蛋白激酶-3 (RIPK3) 的诊断,严重程度估计和预后作用,在患有NEC的早产婴儿中.
- 评估RIPK3与乳酸 (LA) 和C反应蛋白 (CRP) 等已知的标记物一起进行评估.
主要方法:
- 在108名早产婴儿中测量了RIPK3,LA和CRP的血水平 (24名NEC II阶段,18名NEC III阶段,66名对照).
- 使用接收器操作特征 (ROC) 曲线分析来评估诊断性能.
- 与疾病严重程度和完全肠道养 (FEFt) 的时间相关联的RIPK3水平.
主要成果:
- 在患有III期NEC的新生儿中,血RIPK3和LA水平升高.
- 在RIPK3,LA和CRP的合并ROC曲线下,NEC的诊断值达到0.925.
- 在RIPK3水平低于和高于20.06 ng/mL的婴儿之间,FefT的时间显著不同.
结论:
- 血RIPK3是NEC诊断和早产婴儿严重性评估的潜在生物标志物.
- RIPK3水平可以为预后提供信息,并指导NEC恢复后的养策略.
- 需要进一步的研究,以在临床NEC管理协议中建立RIPK3.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


